logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

James C Vary, Jr

This inventor holds 3 USPTO granted patents. Top assignees: Cincinnati Children's Hospital Medical Center, University of Washington, University Research Foundation. Active years: 1997-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James C Vary, Jr. Retrieved from https://idiyas.com/inventor/james-c-vary-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:

goldMedal3 out of 429 
 
Cincinnati Children's Hospital Medical Center
 patents
silverMedal3 out of 2,172 
 
University of Washington
 patents
bronzeMedal1 out of 7 
 
University Research Foundation
 patents
4. 1 out of 471 
 
Washington State University
 patents
where one patent can have more than one assignee

Years Active: 1997-2000

Loading Chart...
3 patents (USPTO):Explore Patents
1. 6040421 - Escherichia coli O157:H7 epithelial adhesion and vaccine (2000-03-21),
2. 5798260 - Escherichia coli O157:H7 epithelial adhesin (1998-08-25),
3. 5654417 - Nucleic acid probes for detecting E. coli O157:H7 (1997-08-05),

Title: The Innovations of James C. Vary, Jr.

Introduction

James C. Vary, Jr. is a notable inventor based in Seattle, Washington. He has made significant contributions to the field of microbiology, particularly in relation to Escherichia coli O157:H7. With a total of three patents to his name, Vary's work has implications for both medical research and public health.

Latest Patents

One of his latest patents focuses on the epithelial adhesion of Escherichia coli O157:H7. This patent includes polypeptides encoded by a continuous segment of chromosomal DNA from E. coli O157:H7, which are isolated on plasmid pSC(overlap) (ATCC No. 69648). These polypeptides encode an adhesin that mediates bacterial colonization of bovine intestines. Additionally, the patent discusses vaccines derived from this research and antibodies directed against the adhesin.

Career Highlights

Throughout his career, Vary has worked with prestigious institutions such as Children's Hospital Medical Center and the University of Washington. His research has contributed to a better understanding of bacterial infections and potential vaccine development.

Collaborations

James C. Vary, Jr. has collaborated with esteemed colleagues, including Phillip I. Tarr and Sima S. Bilge. Their combined expertise has furthered research in the field of microbiology and vaccine development.

Conclusion

James C. Vary, Jr. is a prominent inventor whose work on Escherichia coli O157:H7 has the potential to impact public health significantly. His contributions to microbiology and vaccine research are noteworthy and continue to influence the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…